20,221 Cameco Corporation $CCJ Shares Acquired by Fulcrum Asset Management LLP

Key Points

• Fulcrum Asset Management increased its Cameco stake by 136%, buying 20,221 shares in the third quarter to own 35,094 shares valued at about $3.04 million.
• Other major investors also added or initiated positions, and institutional investors collectively own 70.21% of Cameco.
• Analyst sentiment is broadly positive: MarketBeat reports a “Moderate Buy” consensus from 11 Buy and four Hold ratings, with an average price target of $148.12.

Fulcrum Asset Management LLP boosted its stake in Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 136.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 35,094 shares of the basic materials company's stock after buying an additional 20,221 shares during the period. Fulcrum Asset Management LLP's holdings in Cameco were worth $3,043,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Wellington Management Group LLP acquired a new position in shares of Cameco during the second quarter valued at approximately $212,908,000. Amundi raised its holdings in Cameco by 13.7% during the second quarter. Amundi now owns 2,992,074 shares of the basic materials company's stock worth $304,773,000 after purchasing an additional 359,375 shares in the last quarter. Temasek Holdings Private Ltd bought a new stake in Cameco during the first quarter worth approximately $70,851,000. Royal London Asset Management Ltd. lifted its position in Cameco by 74.6% in the second quarter. Royal London Asset Management Ltd. now owns 275,141 shares of the basic materials company's stock worth $28,026,000 after purchasing an additional 117,592 shares during the period. Finally, Bank of America Corp DE acquired a new stake in Cameco in the second quarter worth approximately $735,498,000. Institutional investors own 70.21% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on CCJ shares. Jefferies Financial Group started coverage on Cameco in a research note on Thursday, September 3rd. They set a "buy" rating and a $138.00 price target for the company. Barclays lowered their price target on Cameco from $95.00 to $89.00 and set an "equal weight" rating on the stock in a research report on Monday, November 2nd. Zacks Research raised Cameco from a "strong sell" rating to a "hold" rating in a research note on Tuesday, November 3rd. Wall Street Zen lowered Cameco from a "hold" rating to a "sell" rating in a report on Saturday, September 19th. Finally, Truist Financial cut their price objective on Cameco from $130.00 to $125.00 and set a "buy" rating for the company in a report on Thursday, October 22nd. Eleven research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $148.12.

Cameco Stock Performance

NYSE:CCJ opened at $75.25 on Tuesday. The company has a 50-day moving average of $86.77 and a 200-day moving average of $102.92. The firm has a market cap of $32.77 billion, a price-to-earnings ratio of 86.36, a price-to-earnings-growth ratio of 1.59 and a beta of 1.18. The company has a current ratio of 2.55, a quick ratio of 2.10 and a debt-to-equity ratio of 0.14. Cameco Corporation has a twelve month low of $66.06 and a twelve month high of $135.24.

Cameco Announces Dividend

The firm also recently announced an annual dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be paid a dividend of C$0.24 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a yield of 22.0%. Cameco's dividend payout ratio is currently 25.76%.

Cameco Profile

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.